Research output per year
Research output per year
Fingerprint
Dive into the research topics where Hubertus Gerardus Maria Leufkens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Research output
- 2 Journal article
-
The EU regulatory landscape of non-biological complex drugs (NBCDs) follow-on products: Observations and recommendations
Klein, K., Stolk, P., De Bruin, M. L., Leufkens, H. G. M., Crommelin, D. J. A. & De Vlieger, J. S. B., 15 May 2019, In: European Journal of Pharmaceutical Sciences. 133, p. 228-235 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making
Coppens, D. G. M., de Wilde, S., Guchelaar, H. J., De Bruin, M. L., Leufkens, H. G. M., Meij, P. & Hoekman, J., Jun 2018, In: Cytotherapy. 20, 6, p. 769-778 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Activities
- 1 Organisation of and participation in conference
-
CORS Annual Conference 2018: Impact of drug regulation on health and society
Marie Louise (Marieke) De Bruin (Organizer), Theis Lange (Organizer), Nikolai C Brun (Organizer), Jens Heisterberg (Organizer), Louise C. Druedahl (Speaker), Christine Erikstrup Hallgreen (Speaker), Mette Gørtz (Speaker), Hubertus Gerardus Maria Leufkens (Speaker), Mathias Møllebæk (Speaker) & Per Sindahl (Speaker)
19 Nov 2018Activity: Participating in or organising an event types › Organisation of and participation in conference